RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,915 | -33.0% | 584,463 | 0.0% | 0.01% | -31.2% |
| Q2 2023 | $7,341 | -23.7% | 584,463 | 0.0% | 0.02% | -30.4% |
| Q1 2023 | $9,626 | +10.2% | 584,463 | 0.0% | 0.02% | +9.5% |
| Q4 2022 | $8,732 | -99.9% | 584,463 | 0.0% | 0.02% | -38.2% |
| Q3 2022 | $13,074,000 | +33.5% | 584,463 | 0.0% | 0.03% | +41.7% |
| Q2 2022 | $9,790,000 | -44.0% | 584,463 | 0.0% | 0.02% | -35.1% |
| Q1 2022 | $17,493,000 | -2.5% | 584,463 | 0.0% | 0.04% | +2.8% |
| Q4 2021 | $17,949,000 | -2.6% | 584,463 | 0.0% | 0.04% | -7.7% |
| Q3 2021 | $18,428,000 | -13.8% | 584,463 | 0.0% | 0.04% | -15.2% |
| Q2 2021 | $21,386,000 | +5.8% | 584,463 | 0.0% | 0.05% | -4.2% |
| Q1 2021 | $20,205,000 | -8.5% | 584,463 | +10.0% | 0.05% | -17.2% |
| Q4 2020 | $22,074,000 | -2.4% | 531,124 | 0.0% | 0.06% | -13.4% |
| Q3 2020 | $22,621,000 | – | 531,124 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |